— Know what they know.
Not Investment Advice

SBX.DE XETRA

SynBiotic SE
1W: -2.9% 1M: -15.0% 3M: -30.9% YTD: -59.3% 1Y: -72.6% 3Y: -85.1% 5Y: -95.9%
€0.79 ($0.89)
-0.06 (-6.71%)
 
Weekly Expected Move ±19.2%
€1 €1 €1 €1 €1
XETRA · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 64 · €4.0M mcap · 3M float · 0.430% daily turnover

Balance Sheet Trends

Total Assets
$35M -14.0% ▼
5Y CAGR: +168.6%
Total Liabilities
$20M +9.9% ▲
Shareholders Equity
$16M -30.1% ▼
5Y CAGR: +129.3%
Cash & Investments
$2M -31.8% ▼
Total Debt
$4M -17.3% ▼
Net Debt
$4M +3.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$13K$6M$3M$967K$89K
Short-Term Investments$0$52K$2M$2M$3M
Cash & ST Investments$13K$6M$3M$3M$2M
Net Receivables$0$922K$727K$306K$565K
Inventory$0$525K$3M$3M$3M
Other Current Assets$225K$176K$3M$1M$1M
Total Current Assets$238K$8M$11M$8M$7M
Property, Plant & Equip.$0$23K$6M$5M$5M
Goodwill & Intangibles$0$27M$43M$27M$23M
Long-Term Investments$0$626K-$2M-$2M-$3M
Other Non-Current Assets$0$52K$3M$2M$3M
Total Non-Current Assets$0$27M$50M$33M$28M
Total Assets$238K$35M$61M$41M$35M
— Liabilities —
Accounts Payable$2K$670K$2M$2M$2M
Short-Term Debt$0$115K$7K$661K$599K
Deferred Revenue$0-$115K-$7K$3M$0
Other Current Liabilities$0$9M$5M$178K$5M
Total Current Liabilities$2K$9M$7M$6M$8M
Long-Term Debt$0$252K$2M$3M$3M
Other Non-Current Liab.$0-$252K$15M$8M$9M
Total Non-Current Liabilities$2K$69K$17M$12M$12M
Total Liabilities$2K$10M$24M$18M$20M
— Equity —
Common Stock$250K$3M$4M$5M$5M
Retained Earnings-$14K-$889K-$14M-$38M-$49M
Accumulated OCI$0$24K$45M$56K$59M
Total Stockholders Equity$236K$25M$35M$23M$16M
Total Liabilities & Equity$238K$35M$61M$41M$35M
— Key Metrics —
Total Debt$0$367K$3M$4M$4M
Net Debt-$13K-$6M-$2M$3M$4M
Total Investments$0$678K$240K$11K$145K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms